Trials / Recruiting
RecruitingNCT05951101
Zenith LAA Occlusion System
Evaluation of the Safety and Performance of the Zenith LAA Occlusion System and Procedure for the Mechanical Closure of the Left Atrial Appendage (LAA)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- AuriGen Medical Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique. Indication - LAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 18 mm and 26 mm
Detailed description
The study objective is to demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith LAA Occlusion System | LAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 17 mm and 25 mm |
Timeline
- Start date
- 2024-03-28
- Primary completion
- 2025-01-31
- Completion
- 2025-12-31
- First posted
- 2023-07-18
- Last updated
- 2024-10-16
Locations
3 sites across 2 countries: Australia, New Zealand
Source: ClinicalTrials.gov record NCT05951101. Inclusion in this directory is not an endorsement.